Survey: Optimism for Health IT Startups in 2018, Skepticism for Amazon Healthcare Partnership | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Survey: Optimism for Health IT Startups in 2018, Skepticism for Amazon Healthcare Partnership

April 26, 2018
by Heather Landi
| Reprints
Click To View Gallery

Despite all the buzz about new entrants disrupting healthcare, the majority of healthcare stakeholders are dubious about the impact of the Amazon/Berkshire Hathaway/JP Morgan healthcare partnership and believe the effort will face substantial challenges and take a lot of time to be successful, according to a survey by venture capital firm Venrock.

For its “2018 Healthcare Prognosis” survey, Venture polled 300 respondents from various parts of the healthcare sector, representing health IT startups, large employers, insurance companies, healthcare providers, academics, government, investors and professional service providers.

Among many topics, the survey polled respondents about their perspectives on new entrants joining the effort to change healthcare for the better and whether these “disruptors” will be successful. Despite the press on the Amazon/Berkshire Hathaway/JP Morgan partnership, which was announced January 30, only 16 percent of respondents viewed that partnership as the most important healthcare event in the past year, trailing the survival of the Affordable Care Act (51 percent say that as the most important healthcare event) and the CVS/Aetna deal (22 percent). One percent said Scott Gottlieb becoming the Food and Drug Administration Commissioner was the most significant event.

Back in January, the CEOs of Amazon, Berkshire Hathaway and JPMorgan Chase & Co. announced the companies are partnering on ways to address healthcare for their U.S. employees with the aim of improving employee satisfaction and reducing costs.

In fact, when asked what the future holds for the Amazon partnership, only 27 percent of respondents said, “They might just pull this thing off,” and the overwhelming majority (73 percent) see the three companies facing substantial challenges. Forty-eight percent responded, “It’s gonna be a long haul,” and 25 percent responded, “They have no idea what they’re getting into.”

However, the majority of respondents also selected Amazon and Apple as the companies most likely to make progress in healthcare in 2018. Half of respondents (51 percent) said Amazon is the company most likely to shake things up, 26 percent choose Apple, 18 percent said Google, 3 percent said IBM and 2 percent said Microsoft.

Looking at challenges to healthcare IT innovation, talent and hiring top the list of respondent’s concerns (cited by 71 percent), followed by regulatory changes (63 percent). This is in contrast to last year when 78 percent of respondents cited regulatory changes under a new Trump Administration as the biggest concern. Concerns about economic uncertainty also dissipated a little, as only 60 percent cited that as a challenge to healthcare IT innovate, compared to 80 percent who cited that as a concern last year.

Regarding the issue of drug pricing, respondents are skeptical that prescription drug prices will be curtailed in the next four years. The majority (75 percent) believe there will still be more talk than action on prescription drug prices, and 19 percent believe nothing will happen.

Looking ahead at the future of hospital consolidation, 59 percent of respondents believe this trend will speed up to consolidate market power prior to MACRA (the Medicare Access and CHIP Reauthorization Act) going into effect. Ten percent believe this trend will slow down due to an emboldened Federal Trade Commission (FTC), and 30 percent see consolidation slowing down due to an inability to create value as larger health systems.

The respondents also provided a crystal ball as to what’s on tap for healthcare IT companies and health IT technologies in 2018, and beyond. With regard to artificial intelligence (AI), the majority (55 percent) believe the technology will play an important role in healthcare, but it will be a few years before the industry sees real-world use cases. Fifty-five percent said it will take two to three years before AI really matters, while 7 percent said the industry will see successful applications and business models during this year. Thirty percent said AI may have an impact, but noted that healthcare adopts technology slowly.

Looking at healthcare IT sub-sectors, respondents forecasted strong growth for telemedicine and big data/analytics. When asked which of the following healthcare IT sub-sectors will experience growth (e.g., some combination of new entrants, influx of capital, customer traction) in the next 12 months, 95 percent said analytics and big data will see either rapid growth or some growth, and 94 percent said telemedicine would see either rapid or some growth. Respondents were more tepid on the growth of wearables and consumer sensors as well as the electronic health records (EHRs)—only 14 percent believe the wearables sector will see rapid growth, and 53 percent said the sector will see some growth, and 42 percent see no growth for the EHR market.

Similarly, respondents showed high confidence (46 percent) that Teladoc’s stock will rise in 2018 (Teladoc is a telemedicine company), while only 3 percent forecasted the same for wearables company Fitbit.

Respondents seemed concerned about bad news from insurance companies, including Oscar and Clover Health, while care providers Iora and One Medical have rosier expectations (75 percent and 70 percent of respondents, respectively, expect good news for those companies in 2018). However, when asked to put on their investor hat and indicate which 2017 early stage financings they regret not having been in, the majority picked Devoted Health and Bright Health, part of the new wave of startups tackling the insurance industry, the survey reports.

Will the IPO market pick up in 2018? IPOs predicted as most likely for One Medical, Health Catalyst and Grand Rounds in 2018, according to the survey respondents.

Overall, according to the survey respondents, the outlook is rosy for healthcare IT companies. The survey found increased optimism about the capital markets and creation of new healthcare IT companies this year, thanks to the stock market's continued rise and plentiful venture funding for this sector. A quarter of respondents (24 percent) believe the capital markets for private healthcare IT companies will remain strong at all stages, which is up from 15 percent in 2017. And, 68 percent of respondents expect the creation of new healthcare IT companies to increase over the next two years, up from 60 percent in 2017.

 

The Health IT Summits gather 250+ healthcare leaders in cities across the U.S. to present important new insights, collaborate on ideas, and to have a little fun - Find a Summit Near You!


/news-item/innovation/survey-optimism-health-it-startups-2018-skepticism-amazon-healthcare
/article/innovation/walgreens-microsoft-ink-strategic-deal-transform-healthcare-delivery

Walgreens, Microsoft Ink Strategic Deal to “Transform Healthcare Delivery”

January 15, 2019
by Rajiv Leventhal, Managing Editor
| Reprints
Observers are pointing to the agreement as a clear sign that the two companies are looking to fend off Amazon’s increasing push into healthcare

Walgreens Boots Alliance Inc. and Microsoft Corp. are joining forces on a major seven-year healthcare partnership that will aim to “deliver innovative platforms that enable next-generation health networks, integrated digital-physical experiences and care management solutions.”

The companies announced today that they will combine the power of Microsoft Azure, Microsoft’s cloud and AI (artificial intelligence) platform, healthcare investments, and new retail solutions with WBA’s customer reach, volume of locations, and outpatient healthcare services to accomplish their goals: to make healthcare delivery more personal, affordable and accessible.

While innovation in healthcare has occurred in pockets, officials of the two companies believe that “there is both a need and an opportunity to fully integrate the system, ultimately making healthcare more convenient to people through data-driven insights.”

As part of the strategic partnership, the companies have committed to a multiyear research and development (R&D) investment to build healthcare solutions, improve health outcomes and lower the cost of care. This investment will include funding, subject-matter experts, technology and tools, officials noted in the announcement. The companies will also explore the potential to establish joint innovation centers in key markets. Additionally, this year, WBA will pilot up to 12 store-in-store “digital health corners” aimed at the merchandising and sale of select healthcare-related hardware and devices.

Executives noted that the companies will focus on connecting WBA stores and health information systems to people wherever they are through their digital devices. What’s more, the integration of information will enable valuable insights based on data science and AI that can allow for improvements such as supporting the transition of healthcare data into more community-based locations and sustainable transformation in healthcare delivery.

And by working with patients’ healthcare providers, the companies will look to proactively engage their patients to improve medication adherence, reduce emergency room visits and decrease hospital readmissions. Core to this model is data privacy, security and consent, which will be key design principles, officials stated.

Just last month, Walgreens Boots Alliance announced that it would work with Verily, an Alphabet company, to develop a medication adherence pilot project. Industry observers are already attesting that the Walgreens-Microsoft collaboration is an obvious sign that the two companies are trying to counter Amazon's growing healthcare footprint.

“Improving health outcomes while lowering the cost of care is a complex challenge that requires broad collaboration and strong partnership between the healthcare and tech industries,” Satya Nadella, CEO, Microsoft, said in a statement today. “Together with Walgreens Boots Alliance, we aim to deliver on this promise by putting people at the center of their health and wellness, combining the power of the Azure cloud and AI technology and Microsoft 365 with Walgreens Boots Alliance’s deep expertise and commitment to helping communities around the world lead healthier and happier lives.”

Notably, the companies will also work on building an ecosystem of participating organizations to better connect consumers, providers—including Walgreens and Boots pharmacists—so that major healthcare delivery network participation will provide the opportunity for people to seamlessly engage in WBA healthcare solutions and acute care providers all within a single platform.

In an emailed statement reacting to today’s news, Forrester analyst Arielle Trzcinski noted, “The technology focus will enable Walgreens to put in place a critical backbone to enable a more connected experience for the customer/patient, as well as support broader interoperability.”

And speaking to the difference between retail pharmacies and traditional care providers, Trzcinski said that retail pharmacies offer an opportunity to engage with the patient much more frequently than at an office visit, giving an example of how chronic care patients see their pharmacist frequently, while some figures indicate that the average diabetic patient sees his or her provider once every six months.

“This gap creates an opportunity for the pharmacist to help monitor the patients’ health and prompt the patient to receive preventative care in the retail clinic or through a virtual care visit. Using an enterprise health cloud, like Azure, you create a more connected ecosystem so that we can share that data with the patient’s additional providers, track outcomes, and intervene earlier when an issue arises,” he said.

Trzcinski also pointed out that up to 20 percent of hospitals are at risk for closure in 2019—according to Morgan Stanley—with most of them located in rural areas. “Consumers will turn to retail locations like Walgreens, Walmart, and CVS for convenient care options as well as virtual care delivery to fill the gap,” he asserted.

Through this agreement, Microsoft becomes WBA’s strategic cloud provider, and WBA plans to migrate the majority of the company’s IT infrastructure onto Microsoft Azure, officials said. Microsoft also plans to roll out Microsoft 365 to more than 380,000 Walgreens employees and stores globally.

 “WBA will work with Microsoft to harness the information that exists between payors and healthcare providers to leverage, in the interest of patients and with their consent, our extraordinary network of accessible and convenient locations to deliver new innovations, greater value and better health outcomes in health care systems across the world,” said Stefano Pessina, executive vice chairman and chief executive officer of WBA.


More From Healthcare Informatics

/article/innovation/how-non-traditional-healthcare-players-can-revolutionize-sector

“Revolutionizing” Healthcare: How Non-Traditional Players are Shaking Up the Sector

January 15, 2019
by Rajiv Leventhal, Managing Editor
| Reprints
Traditional healthcare stakeholders will not be able to slow down new industry entrants such as Amazon, one leading consultant attests

In late November when Amazon announced that it was launching a machine learning service that will aim to mine data from electronic health records (EHRs), company officials, in a blog post, noted that the software, Amazon Comprehend Medical, is “a HIPAA-eligible machine learning service that allows developers to process unstructured medical text and identify information such as patient diagnosis, treatments, dosages, symptoms and signs, and more.”

Two of Amazon’s specialists—Matt Wood, Ph.D., a machine learning expert, and Taha Kass-Hout, M.D., a former FDA chief health informatics officer—noted that a core issue in healthcare and health IT today is that a large amount of critical data is stored as unstructured medical text, such as medical notes, prescriptions, audio interview transcripts, and pathology and radiology reports. “This means that being able to identify this information can be a manual and time-consuming process, which either requires data entry by high skilled medical experts, or teams of developers writing custom code and rules to try and extract the information automatically,” they outlined, adding that Comprehend Medical will instead aim to specifically allow developers “to identify the key common types of medical information automatically, with high accuracy, and without the need for large numbers of custom rules.”

Following the announcement, industry observers were quick to react to Amazon’s latest aggressive push into healthcare, with one consultant for Impact Advisors, Liam Bouchier, a principal with the firm, noting that this latest initiative is simply another example of Amazon “doing what it does best”—working to analyze large data sets as a means to gain meaningful insights into the consumer through a variety of different ways. “This concept does make some in the healthcare industry uncomfortable,” he added.

Another healthcare consultant—Michael Abrams, managing partner at the St. Louis-based Numerof & Associates—agrees that the initiative is exciting at the surface, and believes it speaks to a much larger issue in the health IT market: responding to a significant need to do something constructive with the voluminous amount of data that stakeholders already own.

Taking a step back, Abrams, in a recent interview, explains that one of the core issues that has arisen from healthcare’s digital shift is that having access to digitized data is different from being able to use that data to streamline decisions or improve quality. “Because hospitals rushed to digitization in response to extrinsic [financial] incentives [as part of ARRA/HITECH], they wanted to qualify for federal subsidies, but hadn’t really developed the internal capability to use the data. So, for the most part they are still very early on that learning curve, and the notion of aggregating data, data manipulation, and the insights you can draw from aggregating data, is still a new concept, Abrams says. He adds, “Now that [organizations] have these [EHR] systems and are saddled with substantial upkeep, it’s important to find a way to make it pay off.”

He contends that much of the healthcare delivery community is obsessed with “big data,” but the truth is that “they have hardly scratched the surface using the data they already own.” Abrams asserts, “Many of them don’t understand their own internal operations and don’t understand the cost of doing business— what it costs them to do a knee replacement, for example. All they know is at the end of the year, if they are profitable, it’s all good. Every corner convenience store has SKUs on everything they sell, and they know what the profitably is on every item. How many hospitals can say that? Not many,” he attests.

But according to what Amazon has said regarding its machine learning capabilities, this new software can re-digitize patient records and other clinical notes, analyze them, and pull out key data points, Abrams explains. “This is a very strategic move for Amazon because it already has advanced capabilities in natural language processing. Amazon Web Services has been selling this kind of text analysis software to markets outside of medicine for some time. They have a significant advantage,” he says.

A Vendor Community Satisfied with the Status Quo

An updated brief from the Office of the National Coordinator for Health IT (ONC) last summer revealed that health IT giants Epic and Cerner have continued to maintain the largest EHR market share (22 percent and 24 percent, respectively), based on the proportion of hospitals that reported using the developer's certified products.

These results, though unsurprising, signify to Abrams an oligopoly in that Epic and Cerner account for about half of the hospital market share, with the top-five vendors in this space accounting for roughly 85 percent of the market share. “When you have an oligopoly, you have a lot of large, slow-moving entities,” says Abrams, who also believes that as consolidation increases in the provider market, leading to fewer larger players among hospital systems, it makes it “almost incumbent upon vendors to also become fewer and larger, in order to have a balance of power.”

What’s more, Abrams attests that the EHR vendors with the largest market shares “regard their propriety code and the closed nature of their systems as a defense against encroachment by other, perhaps hungrier players who don’t have that market share. The status quo of a lack of interoperability suits the dominant players,” he says.

Can New Entrants Be Slowed Down?

With all this in mind, while health IT vendors have traditionally been content with incremental change, Abrams strongly believes that outsiders such as Amazon, Apple, and Google “bring the technology and commercial savviness to dramatically shake up what’s been generally a very complacent industry.” He adds, “Players like Amazon have their eye on the next big thing.”

Indeed, the traditional players and the healthcare delivery organizations are, on at least at some level, “terrorized about what these technology companies are going to come up with next,” he says. Consider that in just the last year alone:

  • Amazon, Berkshire Hathaway, and JPMorgan Chase & Co announced they were teaming up on an initiative to improve satisfaction and reduce costs for their companies’ employees.
  • Amazon said it would be part of another endeavor related to healthcare—to remove interoperability barriers and to make progress on adoption of health data standards. For this project, Amazon is teaming up with Microsoft, Google, IBM, and others to jointly commit to support healthcare interoperability by advancing healthcare standards such as HL7 (Health Level Seven International), FHIR (Fast Healthcare Interoperability Resources), and the Argonaut Project.
  • Apple, of course, also had a big announcement in early 2018: that it would be testing its new Health Records feature out with 12 hospitals, inclusive of some of the most prominent healthcare institutions in the U.S. Since that time, more than 100 new organizations have joined the project,  according to Apple. The idea behind the feature is that consumers could see their medical records right on their iPhones.

As such, prior to the past year when non-traditional players began moving more and more into healthcare, providers were “reasonably comfortable with moving as slowly as they could because they thought they had a good fix on the level of pressure and the pace of change that they might expect from the government,” says Abrams.

Adding to this thought, he notes that providers—with the help of industry trade associations—could negotiate with the government on the speed at which certain regulations might come down the pike, depending on how ready stakeholders are. But, Abrams adds, “Nobody can say ‘slow down’ to Amazon; when they want to do something, they are going to do it, and if they have a better solution, it could very well revolutionize the industry.”


Related Insights For: Innovation

/news-item/innovation/should-apple-join-amazonberkshirejpmorgan-joint-healthcare-venture

Should Apple Join the Amazon/Berkshire/JPMorgan Joint Healthcare Venture?

January 10, 2019
by Rajiv Leventhal, Managing Editor
| Reprints

Apple should get involved with the Amazon, Berkshire Hathaway, and JPMorgan Chase & Co joint healthcare venture that the companies announced last year, said Jim Cramer, television personality and former hedge fund manager.

According to a CNBC report this week, Cramer—the host of CNBC's Mad Money and whose charitable trust also owns shares of Apple—said that J.P. Morgan CEO Jamie Dimon would have to be the one to bring Apple involved in the venture, since Warren Buffett's Berkshire Hathaway owns a huge stake in the tech stock that could appear "self-serving.” Said Cramer, “It is really time for, I think, that ecosystem to embrace the Apple ecosystem."

As Healthcare Informatics noted in a news report published last January, “With an ambitious-sounding, if vaguely worded, announcement, three corporate giants—Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. announced Jan. 30 that they were launching an initiative to improve satisfaction and reduce costs for their companies’ employees...The three companies, which bring their scale and complementary expertise to this long-term effort, will pursue this objective through an independent company that is free from profit-making incentives and constraints. The initial focus of the new company will be on technology solutions that will provide U.S. employees and their families with simplified, high-quality and transparent healthcare at a reasonable cost.’”

Although not many details are known about this collaboration, the organizations named Atul Gawande, M.D., as CEO of the initiative, back in June.

Meanwhile, in August, Amazon said it would be part of another endeavor related to healthcare—to remove interoperability barriers and to make progress on adoption of health data standards. For this initiative, Amazon will be teaming up with Microsoft, Google, IBM, and others to jointly commit to support healthcare interoperability by advancing healthcare standards such as HL7 (Health Level Seven International), FHIR (Fast Healthcare Interoperability Resources), and the Argonaut Project.

Over the past year, industry observers have had their eye on non-traditional healthcare players such as Amazon and what they can bring to the table from an innovation and cost-cutting perspective. One recent survey of 100 healthcare organization leaders found that most C-suite executives do have their eyes on Amazon to shake up healthcare.

Apple, of course, also had a big announcement in early 2018: that it would be testing its new Health Records feature out with 12 hospitals, inclusive of some of the most prominent healthcare institutions in the U.S. Since that time, more than 100 new organizations have joined the project,  according to Apple. The idea behind the feature is that consumers could see their medical records right on their iPhones.

In a recent interview with Cramer that aired this week, Apple CEO Tim Cook attested, “I believe, if you zoom out into the future, and you look back, and you ask the question, 'What was Apple's greatest contribution to mankind?' It will be about health.”

See more on Innovation

agario agario---betebet sohbet hattı betebet bahis siteleringsbahis